Sale!

GCSH Gene Glycine Encephalopathy Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GCSH Gene Glycine Encephalopathy Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the GCSH gene, which are associated with Glycine Encephalopathy, also known as Non-Ketotic Hyperglycinemia (NKH). This condition is a rare but severe metabolic disorder that affects the brain and nervous system, leading to a wide range of neurological symptoms. Early detection through genetic testing is crucial for managing the condition and providing appropriate treatment to improve the quality of life for affected individuals.

The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the GCSH Gene Glycine Encephalopathy Genetic Test is 4400 AED. This comprehensive test involves analyzing the patient’s DNA to look for specific mutations in the GCSH gene that are known to cause Glycine Encephalopathy. By identifying these mutations, healthcare providers can confirm a diagnosis, understand the severity of the condition, and tailor treatment plans accordingly. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure accurate and reliable test results, making it a trusted choice for genetic testing in the region.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GCSH Gene Glycine Encephalopathy Genetic Test

Test Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery:

3 to 4 Weeks

Method:

NGS Technology

Test Type:

Neurological Disorders

Doctor:

Neurologist

Test Department:

Genetics

Pre Test Information:

Clinical History of Patient who is going for GCSH Gene Glycine Encephalopathy NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with GCSH Gene Glycine Encephalopathy

Test Details:

The GCSH gene is responsible for producing an enzyme called glycine cleavage system protein H, which is involved in the breakdown of the amino acid glycine in the body. Mutations in the GCSH gene can lead to a rare genetic disorder called glycine encephalopathy, also known as nonketotic hyperglycinemia.

NGS (next-generation sequencing) genetic testing is a type of genetic test that analyzes multiple genes at once using advanced sequencing technologies. NGS can be used to diagnose genetic disorders such as glycine encephalopathy by identifying mutations in the GCSH gene and other related genes.

Individuals with glycine encephalopathy may experience a range of symptoms including seizures, developmental delays, and breathing problems. Early diagnosis and treatment are important for managing the symptoms and preventing complications. Genetic testing can help identify the underlying cause of the disorder and guide appropriate treatment options.

Test Name GCSH Gene Glycine encephalopathy Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GCSH Gene Glycine encephalopathy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GCSH Gene Glycine encephalopathy
Test Details

The GCSH gene is responsible for producing an enzyme called glycine cleavage system protein H, which is involved in the breakdown of the amino acid glycine in the body. Mutations in the GCSH gene can lead to a rare genetic disorder called glycine encephalopathy, also known as nonketotic hyperglycinemia.

NGS (next-generation sequencing) genetic testing is a type of genetic test that analyzes multiple genes at once using advanced sequencing technologies. NGS can be used to diagnose genetic disorders such as glycine encephalopathy by identifying mutations in the GCSH gene and other related genes.

Individuals with glycine encephalopathy may experience a range of symptoms including seizures, developmental delays, and breathing problems. Early diagnosis and treatment are important for managing the symptoms and preventing complications. Genetic testing can help identify the underlying cause of the disorder and guide appropriate treatment options.